NF-κB enhances PD-L1 expression, creating an immunosuppressive barrier surrounding tumors and allowing cancer cells to escape immune monitoring.342 Additionally, NF-κB promotes the production of immunological checkpoint molecules, inhibiting T cell activation and activity inside the TME. Here, CD274 is linked to cancer.